Breast Cancer: A Review on Prognosis and Treatment Methods

Abstract

Breast cancer is a concerning issue among women in general. In recent decades, breast cancer research has evolved quickly. Recent findings offer more treatment choices, better long-term survival for women with breast cancer, and the chance to move towards cures in advanced breast cancer therapy. The prognostic and/or predictive variables identified for the selection of systemic adjuvant therapy for breast cancer are age, race, tumour size, histologic tumour type, axillary nodal status, standard pathologic grade, and hormone receptor status. Polyphenols with anti-cancer properties have been the primary focus of public and medical attention in the effort to reduce cancer incidence. Flavonoid components, including phenethyl isothiocyanate (PIETC), quercetin (Qu), resveratrol (RES), and chlorogenic acid (CGA), which attract a lot of attention from the public, may have the potential to be used as an alternative or complementary medicine in the treatment of breast cancer because they have a wide range of biological attributes. The current trends in existing cancer therapy and prospects for cure are discussed in this review, along with the synergistic effect of polyphenols as a potential therapeutic agent in treating breast cancer. We summarise the evidence by comparing and contrasting diagnostic and treatment methods. Finally, the possibility of breast cancer prevention and more focused treatments was explored.